Carmen Hurtado

510 total citations
24 papers, 314 citations indexed

About

Carmen Hurtado is a scholar working on Epidemiology, Hepatology and Immunology. According to data from OpenAlex, Carmen Hurtado has authored 24 papers receiving a total of 314 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 9 papers in Hepatology and 6 papers in Immunology. Recurrent topics in Carmen Hurtado's work include Hepatitis B Virus Studies (6 papers), Hepatitis Viruses Studies and Epidemiology (5 papers) and Liver Disease Diagnosis and Treatment (4 papers). Carmen Hurtado is often cited by papers focused on Hepatitis B Virus Studies (6 papers), Hepatitis Viruses Studies and Epidemiology (5 papers) and Liver Disease Diagnosis and Treatment (4 papers). Carmen Hurtado collaborates with scholars based in Chile, Spain and United Kingdom. Carmen Hurtado's co-authors include Mauricio Venegas, Francisco Cumsille, Carlos Defilippi, Ana María Madrid, Javier Brahm, Paola Navarrete, Juan A. Ugalde, Martín Gotteland, Catalina Carrasco‐Pozo and Pamela Morales and has published in prestigious journals such as The American Journal of Gastroenterology, Vaccine and The American Journal of Surgery.

In The Last Decade

Carmen Hurtado

21 papers receiving 304 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carmen Hurtado Chile 7 126 107 86 59 55 24 314
Tanju Özkan Türkiye 11 165 1.3× 35 0.3× 119 1.4× 89 1.5× 33 0.6× 29 372
F. D’Aversa Italy 8 113 0.9× 182 1.7× 58 0.7× 100 1.7× 89 1.6× 21 461
María Jesús López Arias Spain 3 226 1.8× 74 0.7× 189 2.2× 65 1.1× 42 0.8× 6 311
Madeline Bertha United States 5 112 0.9× 170 1.6× 20 0.2× 34 0.6× 32 0.6× 7 311
Claudio Rodríguez-Ramos Spain 10 222 1.8× 34 0.3× 211 2.5× 122 2.1× 12 0.2× 12 402
Adam Herber Germany 10 114 0.9× 105 1.0× 93 1.1× 57 1.0× 45 0.8× 23 282
Franziska Durchschein Austria 7 166 1.3× 129 1.2× 130 1.5× 86 1.5× 38 0.7× 17 376
Pavel Wohl Czechia 6 164 1.3× 178 1.7× 98 1.1× 93 1.6× 50 0.9× 19 414
Claudia Simonelli Italy 5 202 1.6× 161 1.5× 11 0.1× 88 1.5× 32 0.6× 9 430
Angelo Tiso Italy 5 158 1.3× 120 1.1× 88 1.0× 159 2.7× 53 1.0× 9 390

Countries citing papers authored by Carmen Hurtado

Since Specialization
Citations

This map shows the geographic impact of Carmen Hurtado's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmen Hurtado with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmen Hurtado more than expected).

Fields of papers citing papers by Carmen Hurtado

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carmen Hurtado. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmen Hurtado. The network helps show where Carmen Hurtado may publish in the future.

Co-authorship network of co-authors of Carmen Hurtado

This figure shows the co-authorship network connecting the top 25 collaborators of Carmen Hurtado. A scholar is included among the top collaborators of Carmen Hurtado based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carmen Hurtado. Carmen Hurtado is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Neumann, Anne, Markus Schwertfeger, Carmen Hurtado, et al.. (2025). Patient-reported outcome and experience measures in cardiovascular disease: a scoping review as part of iCARE4CVD. Journal of Patient-Reported Outcomes. 9(1). 141–141.
2.
Urzúa, Álvaro, et al.. (2022). Colangitis biliar primaria: experiencia de cinco años en el Hospital Clínico de la Universidad de Chile. Revista médica de Chile. 150(7). 889–895.
3.
Hurtado, Carmen, et al.. (2020). Seroprevalencia de Toxoplasma gondii en un hospital universitario en Chile. Revista chilena de infectología. 37(6). 784–787. 2 indexed citations
4.
Sedaño, Rocío, et al.. (2019). Liver transplantation in acute liver failure due to Hepatitis B. Two clinical cases. Annals of Hepatology. 21. 100107–100107. 3 indexed citations
5.
Hurtado, Carmen, et al.. (2019). Decrease in seroprevalence of hepatitis A virus in Santiago, Chile: A decade-long comparison. Gastroenterología y Hepatología (English Edition). 42(4). 248–249. 1 indexed citations
6.
Hurtado, Carmen, et al.. (2018). Seroprevalencia de virus hepatitis E en donantes de sangre en un hospital universitario en Chile. Revista chilena de infectología. 35(4). 455–457. 2 indexed citations
7.
Morales, Pamela, Paola Navarrete, Juan A. Ugalde, et al.. (2016). Impact of Dietary Lipids on Colonic Function and Microbiota: An Experimental Approach Involving Orlistat-Induced Fat Malabsorption in Human Volunteers. Clinical and Translational Gastroenterology. 7(4). e161–e161. 71 indexed citations
8.
Hurtado, Carmen, et al.. (2015). Re-evaluación de seroprevalencia de virus hepatitis E. Revista chilena de infectología. 32(4). 482–484. 3 indexed citations
9.
Villena, Rodolfo, Marcela Zubieta, Carmen Hurtado, et al.. (2015). Seroconversión frente a primovacunación reforzada contra hepatitis B en niños con cáncer. Revista chilena de pediatría. 86(4). 236–243. 2 indexed citations
10.
Venegas, Mauricio, Jaime Poníachik, Francisco Fuster García, et al.. (2014). Genotype F of Hepatitis B: Response to Interferon. Antiviral Therapy. 20(4). 453–456. 3 indexed citations
11.
Saubi, Narcı́s, Ester Gea‐Mallorquí, Pau Ferrer, et al.. (2014). Engineering new mycobacterial vaccine design for HIV–TB pediatric vaccine vectored by lysine auxotroph of BCG. Molecular Therapy — Methods & Clinical Development. 1. 14017–14017. 16 indexed citations
12.
Poníachik, Jaime, Jorge Contreras, José Natalino Macedo Silva, et al.. (2012). Trasplante hepático en cirrosis por virus B: profilaxis con gammaglobulina antiHBs en dosis a "demanda". Revista médica de Chile. 140(1). 78–83.
13.
Gil‐Sanz, Cristina, Núria Climent, Felipe García, et al.. (2011). Ex vivo production of autologous whole inactivated HIV-1 for clinical use in therapeutic vaccines. Vaccine. 29(34). 5711–5724. 8 indexed citations
14.
Lattuca, María Eugenia, Gabriela Malanga, Carmen Hurtado, et al.. (2009). Main features of the oxidative metabolism in gills and liver of Odontesthes nigricans Richardson (Pisces, Atherinopsidae). Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology. 154(4). 406–411. 17 indexed citations
15.
Venegas, Mauricio, et al.. (2008). Prevalence of hepatitis B virus genotypes in chronic carriers in Santiago, Chile. Archives of Virology. 153(11). 2129–2132. 15 indexed citations
16.
Hurtado, Carmen, et al.. (2008). Estudio de enfermedad celíaca en pacientes con enfermedad por hígado graso no alcohólico y con hepatopatías autoinmunes. Gastroenterología y Hepatología. 31(1). 8–11. 6 indexed citations
17.
Madrid, Ana María, Carmen Hurtado, Mauricio Venegas, Francisco Cumsille, & Carlos Defilippi. (2001). Long-Term Treatment With Cisapride and Antibiotics in Liver Cirrhosis: Effect on Small Intestinal Motility, Bacterial Overgrowth, and Liver Function. The American Journal of Gastroenterology. 96(4). 1251–1255. 126 indexed citations
18.
Braghetto, Italo, et al.. (1992). Diagnosis of Acalculous Cholesterolosis in Patients with Typical Biliary Colic Pain. Digestive Surgery. 9(3). 136–140. 3 indexed citations
19.
Braghetto, Italo, et al.. (1988). Triglyceride and cholesterol content in bile, blood, and gallbladder wall. The American Journal of Surgery. 156(1). 26–28. 5 indexed citations
20.
Velasco, María, et al.. (1986). [Infection by HTLV III virus in Chilean homosexuals of median and high socioeconomic levels].. PubMed. 114(9). 823–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026